Publications
30 November 2017
Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
05 January 2017
Comprehensive Mass Spectrometry Based Biomarker Discovery and Validation Platform as Applied to Diabetic Kidney Disease
08 December 2011
Protein Biomarker Research Pipeline for Developing Protein Biomarkers for Diabetic Kidney Disease
09 November 2008
Alpha 2 Giardin is an Assemblage A-specific Protein of Human Infective Giardia duodenalis
16 September 2008
Expression of cardiac a-actin spares extraocular muscles in skeletal muscle a-actin diseases – Quantification of striated a-actins by MRM-mass spectrometry
Categories
Biomarker Discovery
Drug Discovery
iTRAQ
Method Development
Patents
Proteogenomics
Proteomics
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Email
This field is for validation purposes and should be left unchanged.
Company
About Us
Board
Clinical Advisory Board
Mission Statement
Senior Staff
Quality
Customer Testimonials
Careers
Glossary
PromarkerD
Diagnostics
Biomarker Discovery
The Promarker™ Pipeline
Analytical Services
Pharmacokinetic Testing
Biosimilars/Biologics Drug Characterisation
Proteome Mapping
Proteome Quantitation (iTRAQ, TMT, Label-Free)
Targeted Mass Spectrometry (MRM/SRM)
Protein ID by Mass Spectrometry
Post-translational Modifications (PTMs)
Additional Services
Project Consultation
Pricing and Ordering
Terms and Conditions
FAQs
Newsroom
Top Stories
Media Releases
Media Coverage
Videos
Science & Technology
Presentations
Newsletters
Publications
Events
Investors
Share Price and Analyst Coverage
ASX Announcements
Corporate Media
Corporate Presentations
Library
Reports
Corporate Governance
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents